Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Accelerating the translation of molecular fluorescence imaging

Not Accessible

Your library or personal account may give you access

Abstract

The translation of fluorescence molecular imaging is challenged by the “first-of-its-kind” drug (imaging agent) and device combination. Yet upon deploying principles of validation, standardization, and calibration, the translational process can be accelerated. Examples are highlighted.

© 2013 Optical Society of America

PDF Article
More Like This
Bridging NIR fluorescence molecular guidance to clinical translation in surveillance colonoscopy

P. Beatriz Garcia-Allende, Jürgen Glatz, Jolien Tjalma, Anton Terwisscha van Scheltinga, Jan Jacob Koorstra, Jan H. Kleibeuker, Go van Dam, Wouter B. Nagengast, and Vasilis Ntziachristos
MW5C.6 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2013

Clinical Translation and Discovery with Near-infrared Fluorescence Lymphatic Imaging

John C. Rasmussen and Eva M. Sevick-Muraca
AM1P.1 CLEO: Applications and Technology (CLEO:A&T) 2014

Advancing the Translation of Optical Imaging Agents Through Dual Labeling

Ali Azhdarinia, Sukhen C. Ghosh, Kenneth L. Pinkston, Mary A. Hall, Nathaniel Wilganowski, Holly Robinson, Otis Hall, Barrett R. Harvey, and Eva M. Sevick-Muraca
JM3A.3 Bio-Optics: Design and Application (BODA) 2013

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All Rights Reserved